Niagen Bioscience (NAGE) Other Operating Expenses (2011 - 2026)

Niagen Bioscience (NAGE) has 16 years of Other Operating Expenses data on file, last reported at $4.8 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $30.2 million, a 215.5% increase from a year earlier, with the FY2025 full-year figure at $33.5 million, up 457.23% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $4.8 million, down from $8.4 million in the prior quarter.
• Over the last five years, Other Operating Expenses for NAGE reached as high as $8.8 million in Q3 2025 and fell as low as -$17.3 million in Q4 2022.
• Historically, Other Operating Expenses has averaged $2.8 million across 5 years, with a median of $6.0 million in 2023.
• Across the five-year window, Other Operating Expenses tumbled 83.05% in 2022 and soared 630.43% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at -$17.3 million in 2022, then advanced by 13.53% to -$15.0 million in 2023, then jumped by 108.79% to $1.3 million in 2024, then surged by 541.14% to $8.4 million in 2025, then plunged by 43.07% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $4.8 million in Q1 2026, $8.4 million in Q4 2025, and $8.8 million in Q3 2025.